ORGANIZATION

Marshall & Popp, LLC

Lobbying firm · DC

20LDA FILINGS
2LOBBYISTS
0FLY-INS

Federal Lobbying Spend

$580K

Total LDA-disclosed spend (in-house + retained) across all reported periods.

Most recent LDA filing posted April 2026.

Topics in Filings

10

Policy topics named in LD-2 filings. This org's filings are topical rather than positional — these are the issues it's actively lobbying on, even without a stated verb of position.

Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients×48
Drug pricing×28
Trade and tariffs×28
Insurance subsidies×12
Affordable Prescriptions for Patients Act×6
Consolidated Appropriations Act, 2026×6
Drug Competition Enhancement Act×6
PL 119-75×6
Preserving Life-saving Access to Specialty Medicines in America Act×6
Proposals related to Medicare coverage of continuous glucose monitors×6

Bills in Play

6

Bills referenced in this org's LD-2 filing text. Frequency = how many activities reference each.

H.R. 2300

6 mentions

H.R. 1492

6 mentions

H.R. 7148

6 mentions

S. 1040

6 mentions

S. 1041

6 mentions

H.R. 1476

6 mentions

Lobbyists on Record

2
HAZEN MARSHALLformer Policy Director-Senate Majority Leader Mitch Mc…
MONICA POPPformer Chief of Staff/Deputy Chief of Staff, Office of…